Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Thoracic Tumours”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00368992
What this trial is testing

S0536: Cetuximab, Paclitaxel, Carboplatin, and Bevacizumab in Treating Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Adenocarcinoma of the LungAdenosquamous Cell Lung CancerBronchoalveolar Cell Lung Cancer+5 more
National Cancer Institute (NCI) 110
Large-scale testing (Phase 3)Study completedNCT00982111
What this trial is testing

First-line Treatment of Patients With Stage IV Nonsquamous Non-Small Cell Lung Cancer With Necitumumab (IMC-11F8) and Pemetrexed-Cisplatin

Who this might be right for
Non Small Cell Lung Cancer
Eli Lilly and Company 633
Not applicableStudy completedNCT00867711
What this trial is testing

Molecular Predictors of Pemetrexed and Carboplatin Response in Malignant Pleural Mesothelioma (MPM) Patients

Who this might be right for
MALIGNANT PLEURAL MESOTHELIOMA
Istituto Clinico Humanitas 121
Not applicableStudy completedNCT04556344
What this trial is testing

Effectiveness of an Educational Intervention Aimed at Increasing the Emotional Competencies of Patients Under Surveillance After Antineoplastic Treatment of Oesogastric or Bronchopulmonary Cancer

Who this might be right for
Digestive System NeoplasmsThoracic Neoplasms
University Hospital, Lille 26
Testing effectiveness (Phase 2)Study completedNCT02318277
What this trial is testing

Epacadostat (INCB024360) in Combination With Durvalumab (MEDI4736) in Subjects With Selected Advanced Solid Tumors (ECHO-203)

Who this might be right for
Solid TumorsHead and Neck CancerLung Cancer+1 more
Incyte Corporation 176
Not applicableStudy completedNCT03725475
What this trial is testing

Reveal the Patient Characteristics and Treatment Patterns of Stage III Non-small-cell Lung Cancer Patients

Who this might be right for
Non-small-cell Lung Cancer (NSCLC)
AstraZeneca 3,111
Testing effectiveness (Phase 2)Study completedNCT00988936
What this trial is testing

Efficacy Study of [F-18]RGD-K5 Positron Emission Tomography (PET) as a Tool to Monitor Response to an Anti-angiogenic Drug

Who this might be right for
Metastatic Breast CancerMetastatic Colon/Rectum CancerNon-squamous Non-small Cell Lung Cancer
Siemens Molecular Imaging 35
Not applicableStudy completedNCT03319511
What this trial is testing

Thoracic Spinal Anesthesia in Awake Breast Surgery

Who this might be right for
Breast Cancer
Alaa Mazy 70
Testing effectiveness (Phase 2)Study completedNCT01533181
What this trial is testing

Linsitinib or Topotecan Hydrochloride in Treating Patients With Relapsed Small Cell Lung Cancer

Who this might be right for
Recurrent Small Cell Lung Carcinoma
National Cancer Institute (NCI) 44
Testing effectiveness (Phase 2)Looking for participantsNCT05498428
What this trial is testing

Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-small-Cell Lung
Janssen Research & Development, LLC 520
Testing effectiveness (Phase 2)Ended earlyNCT02335944
What this trial is testing

Study of Safety and Efficacy of EGFR-TKI EGF816 in Combination With cMET Inhibitor INC280 in Adult Patients With EGFR Mutated Non Small Cell Lung Cancer.

Who this might be right for
Non Small Cell Lung Cancer
Novartis Pharmaceuticals 177
Large-scale testing (Phase 3)Study completedNCT01631357
What this trial is testing

Study of Chemotherapy Combination With Autologous Cytokine-Induced Killer Cell Immunotherapy to Treat Lung Cancer

Who this might be right for
Non-small Cell Lung CancerSquamous Cell Carcinoma
Tianjin Medical University Cancer Institute and Hospital 96
Not applicableUnknownNCT04553601
What this trial is testing

Molecular Imaging Visualization of Tumor Heterogeneity in Non-small Cell Lung Cancer

Who this might be right for
NSCLCPET/CTBiopsy+3 more
The First Affiliated Hospital of Xiamen University 150
Early research (Phase 1)Looking for participantsNCT04842812
What this trial is testing

Engineered TILs/CAR-TILs to Treat Advanced Solid Tumors

Who this might be right for
Liver CancerLung CancerBreast Cancer+5 more
Second Affiliated Hospital of Guangzhou Medical University 40
Early research (Phase 1)Not Yet RecruitingNCT07650357
What this trial is testing

CLSP 5282 in HLA-A*03:01 Positive Adult Patients With Solid Tumors (SENTINEL-101)

Who this might be right for
Advanced Solid TumorNon Small Cell Lung CancerPancreatic Carcinoma+1 more
Clasp Therapeutics, Inc. 140
Early research (Phase 1)Study completedNCT01626001
What this trial is testing

Imaging Study Compare 4DCT Image

Who this might be right for
Esophagus CancerLung Cancer
M.D. Anderson Cancer Center 52
Not applicableUnknownNCT01739881
What this trial is testing

Evaluating the Pulmonary Nodule With Imaging and Biomarkers

Who this might be right for
Lung Cancer
National University Hospital, Singapore 60
Not applicableLooking for participantsNCT06100328
What this trial is testing

Characteristics of Cardiac Tumor and the Risk Stratification of Subsequent Adverse Events (UNIQUE)

Who this might be right for
Cardiac Tumor
First Affiliated Hospital Xi'an Jiaotong University 40
Testing effectiveness (Phase 2)UnknownNCT05668767
What this trial is testing

Surufatinib in Combination of Durvalumab and EP/EC in the Firstly-line Treatment of ES-SCLC

Who this might be right for
Extensive-stage Small-cell Lung Cancer
Beijing Chest Hospital 20
Testing effectiveness (Phase 2)WithdrawnNCT02662634
What this trial is testing

A Safety and Feasibility Study of AGS-003-LNG for the Treatment of Stage 3 Non Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
GU Research Network, LLC
Next Page